Barros L F, Chagas A C, da Luz P L, Pileggi F
Divisão de Pesquisa Experimental, Instituto do Coração (INCOR), Faculdade de Medicina de São Paulo, Universidade de São Paulo, Brazil.
Int J Cardiol. 1995 Jan 27;48(1):3-9. doi: 10.1016/0167-5273(94)02208-z.
The effects of plasma magnesium elevation on myocardial necrosis were tested in anesthetized dogs submitted to left anterior descending coronary artery occlusion and reperfusion. Eighteen dogs were treated with magnesium sulfate soon after the coronary occlusion in order to treble the plasma concentration, while 18 others remained as controls. The treatment determined only slight reductions in the heart rate and in the arterial blood pressure, from the beginning to the end of the experiment. The percent necrosis of the ischemic myocardium was determined by staining and weighting the normal, the preserved and the necrotic areas. Necrosis was noticed in 63.7 +/- 16.8% and 44.2 +/- 20.8% of the risk area in the control and treated groups, respectively (P = 0.004). It is concluded that the treatment has protected the ischemic/reperfused myocardium reducing the final necrosis of the risk area by about 30%. This effect may be ascribed to the hemodynamic changes determined by magnesium sulfate infusion as well as to metabolic actions during ischemia and reperfusion.
在接受左冠状动脉前降支闭塞和再灌注的麻醉犬中,测试了血浆镁升高对心肌坏死的影响。18只犬在冠状动脉闭塞后不久接受硫酸镁治疗,以使血浆浓度增加两倍,而另外18只犬作为对照。从实验开始到结束,该治疗仅使心率和动脉血压略有降低。通过对正常、保留和坏死区域进行染色和称重,确定缺血心肌的坏死百分比。对照组和治疗组中,风险区域的坏死分别为63.7±16.8%和44.2±20.8%(P = 0.004)。得出的结论是,该治疗保护了缺血/再灌注心肌,使风险区域的最终坏死减少了约30%。这种作用可能归因于硫酸镁输注所引起的血流动力学变化以及缺血和再灌注期间的代谢作用。